Skip to main content
. 2023 Jul 24;11:40. doi: 10.1038/s41413-023-00262-z

Fig. 5.

Fig. 5

Mechanisms by which SMAs inhibit osteoclast (OC) formation. SMAs inhibit OC formation by regulating the NF-κB, MAPKs, PK13/ATK, ORV, and other signaling pathways. OCs are large multinucleated bone-resorbing cells derived from monocytes. The preosteoclasts (pre-OCs) generated by monocytes migrate to the bone surface and fuse into multinucleated OCs through the activation of RANKL and then develop into mature OCs. RANKL is generated by OBs, osteoprogenitor cells, osteocytes, and stromal cells. M-CSF binds to the transmembrane receptor CSF-1R expressed by pre-OCs to promote the proliferation and survival of the pre-OCs. The NF-κB pathway is mediated by the upstream RANKL-RANK complex, which leads to the differentiation of pre-OCs into OCs via the activation of downstream signaling molecules such as NF-κB, c-Fos, and NFATc1. OC ruffled-border H+-ATPases (ORVs) emerge at the OC ruffled border and display novel functions in OCs to solubilize bone minerals by acidifying an extracellular resorption compartment